An older chemo mix helped some people whose melanoma had spread
Original title: Utility of Chemotherapy for Metastatic Melanoma in the Contemporary Era and Experience with Modified Vinblastine-Cisplatin-Temozolomide at a Tertiary Care Center.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
Doctors only looked back at records of 10 people, so it is not proven yet.
The short version
An older chemo mix shrank melanoma in 50% of a small group of 10 people.
What was studied. Doctors looked back at records of 10 people whose melanoma came back or kept growing. Each got a changed chemo mix. It used vinblastine, cisplatin, and temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary.
What they found. Tumors shrank in 50% of the people. Cancer held steady or shrank in 70%. Eight people had cancer in the brain. In them, brain cancer held steady or shrank in 100%. Four people had serious side effects, mostly tiredness and low blood counts.
What this means, and what it doesn't
What it could mean: This mix may be an option if newer melanoma drugs or a trial are out of reach. It may hold the cancer back for a while. Ask your doctor if it fits your case.
What it doesn't mean: This is not a cure. It was a look back at records of only 10 people, not a planned trial. A group that small can give results that do not hold up later. It does not replace newer melanoma treatments. The doctors saw it as a bridge while people wait for those.
Source: PubMed, October 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.